Richard Pye has been appointed as chief financial officer and executive director at clinical AI technology company Sensyne Health.
He was previously Sensyne’s chief investment officer.
Michael Norris, Sensyne’s interim CFO, and Geoff Race, co-founder and CFO of Minerva Neurosciences, have joined the Sensyne board as non-executive directors.
Sir Bruce Keogh, chair of Sensyne Health, said: “I am delighted to welcome Richard, Geoff and Michael to the board of Sensyne. I would like to thank Michael for his excellent service as interim CFO and I am delighted he has agreed to stay with the business as a non-executive director. These senior appointments, combined with our strong team, will help us boost commercial momentum and accelerate the scaling of the business internationally.”